Related Experiment Video
Updated: May 19, 2026
09:30
Efficient and Rapid Generation of CAR-T and Cytokine-Induced Killer Cells in GMP-scalable Devices
Published on: December 5, 2025
Chemokine-based immunotherapy: delivery systems and combination therapies
1Molecular Immunology & Vaccine Research Lab, Pasteur Institute of Iran, Tehran 13164, Iran.
Immunotherapy
|September 6, 2012
Summary
Chemokines, crucial for immune cell movement, are being engineered into novel therapies. These strategies, including viral vectors and antibody fusions, enhance immune responses against diseases, particularly cancer.
Area of Science:
- Immunology
- Molecular Biology
- Biotechnology
Background:
- Chemokines orchestrate leukocyte migration via G-protein-coupled receptors, playing a vital role in immune responses.
- Developing effective delivery systems for chemokines is crucial for therapeutic applications in disease treatment.
Purpose of the Study:
- This review explores the diverse strategies for utilizing chemokines in therapeutic interventions.
- Emphasis is placed on the application of chemokines in generating anti-tumor immunity.
Main Methods:
- Discussion of viral and mutant viral vectors expressing chemokines.
- Overview of genetically modified cells (dendritic cells, tumor cells) engineered for chemokine expression.
- Exploration of chemokine fusion with antibodies or antigenic moieties for targeted delivery and enhanced immune stimulation.
Main Results:
- Chemokines, when used as adjuvants, significantly enhance antitumor immunity.
- Codelivery of chemokines with antigens or their fusion to antigenic moieties boosts immune responses.
- Various engineered systems demonstrate potential for targeted immune modulation.
Conclusions:
- Chemokine-based strategies offer promising avenues for developing novel immunotherapies.
- Targeted delivery and adjuvant applications of chemokines are key to maximizing their therapeutic potential, especially in oncology.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...